ArticleHealth and quality of life outcomes2026
The association between disease status and health-related quality of life: evidence from a cross-sectional survey across mainland China.
Article in Health and quality of life outcomes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundThis study aimed to assess the health-related quality of life (HRQoL) among Chinese adults with varying disease statuses.
methodsA cross-sectional study was conducted between June 20 and August 31, 2023 across China. HRQoL was measured using the EQ-5D-5L utility index (UI) and EQ-Visual Analogue Scale (EQ-VAS). Kruskal-Wallis tests compared HRQoL across disease groups, chi-square tests compared problem prevalence within each EQ-5D-5L dimension across disease groups, and Tobit regression examined associations between disease status and HRQoL. Subgroup and interaction analyses assessed effect modification by age, gender, education, employment, and smoking status.
resultsA total of 42,447 participants were included (healthy: 33,408; single chronic disease: 5,084; multimorbidity: 3,955). HRQoL showed a clear gradient: median UI and EQ-VAS scores were 1 (0.95-1) and 80 (64–90) in healthy individuals, 0.95 (0.89-1) and 75 (61–83) in the single chronic disease group, and 0.89 (0.73-1) and 69 (54–81) in the multimorbidity group (all P [Formula: see text] 0.001). Problem prevalence differed significantly among groups for all EQ-5D-5L dimensions. Age, education, smoking, and employment status modified associations between disease status and UI, yet single chronic disease and multimorbidity remained consistently linked to lower UI across all subgroups.
conclusionsHRQoL declined from healthy individuals to those with single chronic disease and multimorbidity. The modifying effects of age, education, smoking, and employment status highlight priority subgroups for targeted interventions. STUDY REGISTRATION: Chinese Clinical Trial Register (ChiCTR), ChiCTR2300072573. Registration Date: June 16, 2023 [Observational study].
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.